v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (1,434,000) $ (447,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 2,358,000 2,593,000
Deferred income tax benefit (595,000) (40,000)
Amortization of deferred costs 13,000 16,000
Compensation expense related to restricted stock awards 1,066,000 1,130,000
Provision for credit losses 196,000 225,000
(Gain) Loss on sale of assets, net (1,550,000) 307,000
Other gains   (27,000)
Gain on insurance claim (56,000)  
Non-cash rent expense 407,000  
Non-cash interest income (381,000)  
Barter revenue (net) (73,000) (163,000)
Deferred and other compensation (128,000) (98,000)
Changes in operating lease assets and liabilities (net) (32,000) 705,000
Changes in assets and liabilities:    
(Increase) decrease in current assets (439,000) (1,501,000)
(Decrease) increase in accounts payable, accrued expenses, and other liabilities (629,000) (581,000)
Total adjustments 157,000 2,566,000
Net cash (used in) provided by operating activities (1,277,000) 2,119,000
Cash flows from investing activities:    
Purchase of short-term investments (11,758,000) (9,031,000)
Redemption of short-term investments 11,758,000 9,031,000
Acquisition of property and equipment (Capital Expenditures) (2,041,000) (2,010,000)
Proceeds from sale and disposal of assets 2,323,000 10,000
Proceeds from insurance claims, redemption of investments and other 56,000 27,000
Net cash provided by (used in) investing activities 338,000 (1,973,000)
Cash flows from financing activities:    
Cash dividends paid (3,176,000) (3,215,000)
Purchase of treasury shares (13,000)  
Net cash used in financing activities (3,189,000) (3,215,000)
Net decrease in cash and cash equivalents (4,128,000) (3,069,000)
Cash and cash equivalents, beginning of period 22,506,000 18,860,000
Cash and cash equivalents, end of period $ 18,378,000 $ 15,791,000